Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V.

2 trials 1 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 2 trials by condition, phase, country and more.

Open in Search →
2 Registered trials
1 Recruiting
1 Completed trials
6 Countries active
4 Unique IMPs
100% Results reported
Phase II: 2
100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Fallopian tube cancer 2 Ovarian cancer recurrent 1 Peritoneal cancer index 1 Ovarian cancer 1 Fallopian tube cancer stage IV 1 Ovarian cancer stage IV 1 Fallopian tube cancer stage III 1 Ovarian cancer stage III 1

Top IMPs

NIRAPARIB TOSILATE MONOHYDRATE 1 PEMBROLIZUMAB 1

All trials

2 total

Showing 1–2 of 2 trials

← All sponsors A–Z